Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Role of Transforming Growth Factor-β in Tumor Invasion and Metastasis

  • Kim, Eun-Sook (College of Pharmacy, Duksuhng Women's University) ;
  • Moon, Aree (College of Pharmacy, Duksuhng Women's University)
  • Published : 2007.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Cancer metastasis is a major determinant of cancer patient mortality. Mounting evidence favors a strong positive role for $TGF-{\beta}$ in human cancer progression. The complex pattern on cross-talk of $TGF-{\beta}$ and the related other signaling pathways is an important area of investigation that will ultimately contribute to understanding of the bifunctional role of $TGF-{\beta}$ in cancer progression. This review summarizes some of the current understanding of $TGF-{\beta}$ signaling with a major focus in its contribution to the tumor cell invasion and metastasis. Five issues are addressed in this review: (1) $TGF-{\beta}$ signaling, (2) $TGF-{\beta}$ and EMT, (3) $TGF-{\beta}$ and MMP, (4) $TGF-{\beta}$ and Ras, and (5) Role of $TGF-{\beta}$ in invasion and metastasis. Due to the bifunctional cellular effects of $TGF-{\beta}$, as a tumor promoter and a tumor suppressor, more precisely defined $TGF-{\beta}$ signaling pathways need to be elucidated. According to the current literature, $TGF-{\beta}$ is clearly a major factor stimulating tumor progression through a complex spectrum of the interplay and cross-talk between various signaling molecules. Understanding the role of $TGF-{\beta}$ in invasion and metastasis will provide valuable information on establishing strategies to manipulate $TGF-{\beta}$ signaling which should be a high priority for the development of anti-metastatic therapeutics.

Keywords

References

  1. Akhurst, R.J. and Balmain, A. (1999). Genetic events and the role of TGF-$\beta$ in epithelial tumor progression. J. Pathol., 187, 82-90 https://doi.org/10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8
  2. Akhurst, R.J. and Derynck, R. (2001). TGF-$\beta$ signaling in cancer- a double-edged sword. Trends Cell Biol., 11, S44- S51
  3. Alexandrow, M.G. and Moses, H.L. (1995). Transforming growth factor $\beta$ and cell cycle regulation. Cancer Res., 55, 1452- 1457
  4. Atfi, A., Djelloul, S., Chastre, E., Davis, R. and Gespach, C. (1997). Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor $\beta$-mediated signaling. J. Biol. Chem., 272, 1429-1432 https://doi.org/10.1074/jbc.272.3.1429
  5. Attisano, L. and Wrana, J.L. (2002). Signal transduction by the TGF-$\beta$ superfamily. Science, 296, 1646-1647 https://doi.org/10.1126/science.1071809
  6. Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L. and Arteaga, C.L. (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor $\beta$-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem., 275, 36803-36810 https://doi.org/10.1074/jbc.M005912200
  7. Bakin, A.V., Rinehart, C., Tomlinson, A.K. and Arteaga, C.L. (2002). p38 mitogen-activated protein kinase is required for TGF$\beta$-mediated fibroblastic transdifferentiation and cell migration. J. Cell. Sci., 115, 3193-3206
  8. Bhowmick, N.A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C.A., Engel, M.E., Arteaga, C.L. and Moses, H.L. (2001). Transforming growth factor-$\beta$ mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell., 12, 27-36 https://doi.org/10.1091/mbc.12.1.27
  9. Bierie, B. and Moses, H.L. (2006). TGF-$\beta$ and cancer. Cytokine Growth Factor Rev., 17, 29-40 https://doi.org/10.1016/j.cytogfr.2005.09.006
  10. Blobe, G.C., Schiemann, W.P. and Lodish, H.F. (2000). Role of transforming growth factor $\beta$ in human disease. N. Engl. J. Med., 342, 1350-1358 https://doi.org/10.1056/NEJM200005043421807
  11. Bourne, H.R., Sanders, D.A. and McCormick, F. (1991). The GTPase superfamily: conserved structure and molecular mechanism. Nature, 349, 117-127 https://doi.org/10.1038/349117a0
  12. Boyer, B., Valles, A.M. and Edme, N. (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol., 60, 1091-1099 https://doi.org/10.1016/S0006-2952(00)00427-5
  13. Campbell, C.E., Flenniken, A.M., Skup, D. and Williams, B.R. (1991). Identification of a serum- and phorbol esterresponsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem., 266, 7199-7206
  14. Clair, T., Miller, W.R. and Cho-Chung, Y.S. (1987). Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res., 47, 5290-5293
  15. Clark, G.J. and Der, C.J. (1995). Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res. Treat., 35, 133-144 https://doi.org/10.1007/BF00694753
  16. Cui, W., Fowlis, D.J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, R.J. (1996). TGF$\beta$ inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531-542 https://doi.org/10.1016/S0092-8674(00)80127-0
  17. de Caestecker, M.P., Piek, E. and Roberts, A.B. (2000). Role of transforming growth factor-$\beta$ signaling in cancer. J. Natl. Cancer Inst., 92, 1388-1402 https://doi.org/10.1093/jnci/92.17.1388
  18. De Larco, J.E. and Todaro, G.J. (1978). Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. U.S.A., 75, 4001-4005
  19. Derynck, R. and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-$\beta$ family signalling. Nature, 425, 577-584 https://doi.org/10.1038/nature02006
  20. Dumont, N., Bakin, A.V. and Arteaga, C.L. (2003). Autocrine transforming growth factor-$\beta$ signaling mediates Smadindependent motility in human cancer cells. J. Biol. Chem., 278, 3275-3285 https://doi.org/10.1074/jbc.M204623200
  21. Ellenrieder, V., Hendler, S.F., Ruhland, C., Boeck, W., Adler, G. and Gress, T.M. (2001). TGF-$\beta$-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase- 2 and the urokinase plasminogen activator system. Int. J. Cancer., 93, 204-211 https://doi.org/10.1002/ijc.1330
  22. Elliott, R.L. and Blobe, G.C. (2005). Role of transforming growth factor $\beta$ in human cancer. J. Clin. Oncol., 23, 2078-2093 https://doi.org/10.1200/JCO.2005.02.047
  23. Festuccia, C., Bologna, M., Gravina, G.L., Guerra, F., Angelucci, A., Villanova, I., Millimaggi, D. and Teti, A. (1999). Osteoblast conditioned media contain TGF$\beta$1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int. J. Cancer., 81, 395-403 https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3<395::AID-IJC13>3.0.CO;2-V
  24. Fidler, I.J. (1990). Critical factors in the biology of human cancer metastasis. Cancer Res., 50, 6130-6138
  25. Forrester, E., Chytil, A., Bierie, B., Aakre, M., Gorska, A.E., Sharif-Afshar, A.R., Muller, W.J. and Moses, H.L. (2005). Effect of conditional knockout of the type II TGF$\beta$ receptor gene in mammary epithelia on mammary gland development and polyomavirus middle Tantigen induced tumor formation and metastasis. Cancer Res., 65, 2296-23 https://doi.org/10.1158/0008-5472.CAN-04-3272
  26. Frixen, U.H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. and Birchmeier, W. (1991). E-Cadherin- mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell. Biol., 113, 173-185 https://doi.org/10.1083/jcb.113.1.173
  27. Giannelli, G., Bergamini, C., Fransvea, E., Sgarra, C. and Antonaci, C. (2005). Laminin 5 with transforming growth factor-$\beta$ induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology, 129, 1375- 1383 https://doi.org/10.1053/j.gastro.2005.09.055
  28. Hanafusa, H., Ninomiya-Tsuji, J., Masuyama, N., Nishita, M., Fujisawa, J. and Shibuya, H. (1999). Involvement of the p38 mitogenactivated protein kinase pathway in transforming growth factor $\beta$-induced gene expression. J. Biol. Chem., 274, 27161-27167 https://doi.org/10.1074/jbc.274.38.27161
  29. Hartsough, M.T. and Mulder, K.M. (1995). Transforming growth factor $\beta$ activation of p44mapk in proliferating cultures of epithelial cells. J. Biol. Chem., 270, 7117-7124 https://doi.org/10.1074/jbc.270.13.7117
  30. Iglesias, M., Frontelo, P., Gamallo, C. and Quintanilla, M. (2000). Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene, 19,4134-4145 https://doi.org/10.1038/sj.onc.1203764
  31. Ionescu, A.M., Schwarz, E.M., Zuscik, M.J., Drissi, H., Puzas, J.E., Rosier, R.N. and O'Keefe, R.J. (2003). ATF2 cooperates with Smad3 to mediate TGF-$\beta$ effects on chondrocyte maturation. Exp. Cell Res., 288, 198-207 https://doi.org/10.1016/S0014-4827(03)00181-2
  32. Itoh, S., Itoh, F., Goumans, M.J. and ten Dijke, P. (2000). Signaling of transforming growth factor-$\beta$ family members through Smad proteins. Eur. J. Biochem., 267, 6954-6967 https://doi.org/10.1046/j.1432-1327.2000.01828.x
  33. Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin, C.H. and ten Dijke, P. (2003). Elucidation of Smad requirement in transforming growth factor-$\beta$ type I receptor- induced responses. J. Biol. Chem., 278, 3751-3761 https://doi.org/10.1074/jbc.M208258200
  34. Johansson, N., Ala-aho, R., Uitto, V., Grenman, R., Fusenig, N.E. and Lopez-Otin, C. (2000). Expression of collagenase- 3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogenactivated protein kinase. J. Cell. Sci., 113, 227-235
  35. Karsdal, M.A., Fjording, M.S., Foged, N.T., Delaisse, J.M. and Lochter, A. (2001). Transforming growth factor-$\beta$-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase- and matrix metalloproteinase dependent pathway. J. Biol. Chem., 276, 39350-39358 https://doi.org/10.1074/jbc.M008738200
  36. Kim, M.S., Lee, E.J., Kim, H.R. and Moon, A. (2003). p38 Kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res., 63, 5454-5461
  37. Kim, E.S., Kim, M.S. and Moon, A. (2004). TGF-$\beta$-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int. J. Oncol., 25, 1375-1382
  38. Kim, E.S., Kim, M.S. and Moon, A. (2005). Transforming growth factor (TGF)-$\beta$ in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine, 29, 84-91 https://doi.org/10.1016/j.cyto.2004.10.001
  39. Kim, E.S., Sohn, Y.W. and Moon, A. (2007). TGF-$\beta$-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett., 252, 147-156 https://doi.org/10.1016/j.canlet.2006.12.016
  40. Kitagawa, K., Murata, A., Matsuura, N., Tohya, K., Takaichi, S., Monden, M. and Inoue, M. (1996). Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-$\beta$1. Int. J. Cancer., 66, 91-97 https://doi.org/10.1002/(SICI)1097-0215(19960328)66:1<91::AID-IJC16>3.0.CO;2-E
  41. Lee, J.M., Dedhar, S., Kalluri, R. and Thompson, E.W. (2006). The epithelial-mesencymal transiton: new insights in signaling, development, and disease. J. Cell Biol., 172, 973-977 https://doi.org/10.1083/jcb.200601018
  42. Li, W., Qiao, W., Chen, L., Xu, X., Yang, X., Li, D., Li, C., Brodie, S.G., Meguid, M.M. and Hennighausen, L. (2003). Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development, 130, 6143-6153 https://doi.org/10.1242/dev.00820
  43. Lin, S.W., Lee, M.T., Ke, F.C., Lee, P.P., Huang, C.J. and Ip, M.M. (2000). TGFa1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103. Clin. Exp. Metastasis., 18, 493-499 https://doi.org/10.1023/A:1011888126865
  44. Liotta, L.A. and Stetler-Stevenson, W.G. (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51, 5054-5059
  45. Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z. and Bissell, M.J. (1997). Matrix metalloproteinase stromelysin- 1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol., 139, 1861-1872 https://doi.org/10.1083/jcb.139.7.1861
  46. Maehara, Y., Kakeji, Y., Kabashima, A., Emi, Y., Watanabe, A., Akazawa, K., Baba, H., kohnoe, S. and Sugimachi, K. (1999). Role of transforming growth factor-$\beta$1 in invasion and metastasis in gastric carcinoma. J. Clin. Oncol., 17, 607-614 https://doi.org/10.1200/JCO.1999.17.2.607
  47. Manning, G., Whyte, D.B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science, 298, 1912-1934
  48. Markowitz, S.D. and Roberts, A.B. (1996). Tumor suppressor activity of the TGF-$\beta$ pathway in human cancers. Cytokine Growth Factor Rev., 7, 93-102 https://doi.org/10.1016/1359-6101(96)00001-9
  49. Marshall, M.S. (1995). Ras target proteins in eukaryotic cells. FASEB J., 9, 1311-1318 https://doi.org/10.1096/fasebj.9.13.7557021
  50. Massague, J. (1998). TGF-$\beta$ signal transduction. Annu. Rev. Biochem., 67, 753-791 https://doi.org/10.1146/annurev.biochem.67.1.753
  51. Massague, J. (2000). How cells read TGF-$\beta$ signals. Nat. Rev. Mol. Cell Biol., 1, 169-178 https://doi.org/10.1038/35043051
  52. Mauviel, A., Chung, K.Y., Agarwal, A., Tamai, K. and Uitto, J. (1996). Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-$\beta$ in fibroblasts and keratinocytes. J. Biol. Chem., 271, 10917-10923 https://doi.org/10.1074/jbc.271.18.10917
  53. McEarchern, J.A., Kobie, J.J., Mack, V., Wu, R.S., Meade-Tollin, L. and Arteaga, C.L. (2001). Invasion and metastasis of a mammary tumor involves TGF-$\beta$ signaling. Int. J. Cancer., 91, 76-82 https://doi.org/10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8
  54. Miettinen, P.J., Ebner, R., Lopez, A.R. and Derynck, R. (1994). TGF-$\beta$ induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol., 127, 2021-2036 https://doi.org/10.1083/jcb.127.6.2021
  55. Moses, H.L., Tucker, R.F., Leof, E.B., Coffey, R.J. Jr., Halper, J. and Shipley, G.D. (1985). Type-$\beta$ transforming growth factor is a growth stimulator and a growth inhibitor (Feramisco, J., Ozanne, B and Stiles, C. Eds.). Cold Spring Harbor Laboratories., New York, pp 65-71
  56. Mulder, K.M. and Morris, S.L. (1992). Activation of p21ras by transforming growth factor $\beta$ in epithelial cells. J. Biol. Chem., 267, 5029-5031
  57. Mulder, K.M. (2000). Role of Ras and Mapks in TGF- $\beta$signaling. Cytokine Growth Factor Rev., 11, 23-35 https://doi.org/10.1016/S1359-6101(99)00026-X
  58. Muraoka, R.S., Dumont, N., Ritter, C.A., Dugger, T.C., Brantley, D.M. and Chen, J. (2002). Blockade of TGF-$\beta$ inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest., 109, 1551-1559 https://doi.org/10.1172/JCI0215234
  59. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H. and Reichmann, E. (1996). TGF-$\beta$1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev., 10, 2462-2477 https://doi.org/10.1101/gad.10.19.2462
  60. Oft, M., Heider, K.H. and Beug, H. (1998). TGF-$\beta$ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol., 8, 1243-1252 https://doi.org/10.1016/S0960-9822(07)00533-7
  61. Oft, M., Akhurst, R.J. and Balmain, A. (2002). Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell. Biol., 4, 487-494
  62. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.H. and ten Dijke, P. (1999). TGF-$\beta$ type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci., 112, 4557-4568
  63. Platten, M., Wick, W. and Weller, M. (2001). Malignant glioma biology: role for TGF-$\beta$ in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech., 52, 401-410 https://doi.org/10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C
  64. Portella, G., Cumming, S.A., Liddell, J., Cui, W., Ireland, H., Akhurst, R.J. and Balmain, A. (1998). Transforming growth factor $\beta$ is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ., 9, 393-404
  65. Reiss, M. and Barcellos-Hoff, M.H. (1997). Transforming growth factor $\beta$ in breast cancer: a working hypothesis. Breast Cancer Res. Treat., 45, 81-95 https://doi.org/10.1023/A:1005865812918
  66. Roberts, A.B., Anzano, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F. and Sporn, M.B. (1985). Type $\beta$ transforming growth factor: A bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. U.S.A., 82, 119-123
  67. Roberts, A.B. and Sporn, M.B. (1990). Peptide growth factors and their receptors-Handbook of experimental pharmacology (Sporn, M.B and Roberts, A.B. Eds.). Springer, Heidelberg, pp. 419-472
  68. Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Hofler, H. and Becker, K.F. (2002). Differential expression of the epithelial-mesenchymal transition regulators anail, SIP1, and twist in gastric cancer. Am. J. Pathol., 161, 1881-1891 https://doi.org/10.1016/S0002-9440(10)64464-1
  69. Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Flanders, K.C., Yoo, J., Anzano, M. and Liu, C.Y. (2004). Smad3 signaling is required for epithelialmesenchymal transition of lens epithelium after injury. Am. J. Pathol., 164, 651-663 https://doi.org/10.1016/S0002-9440(10)63153-7
  70. Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T. and Ishii, S. (1999). ATF2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-$\beta$ signaling. J. Biol. Chem., 274, 8949- 8957 https://doi.org/10.1074/jbc.274.13.8949
  71. Santibanez, J.F., Guerrero, J., Quintanilla, M., Fabra, A. and Martinez, J. (2002). Transforming growth factor-$\beta$1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem. Biophys. Res. Commun., 296, 267-273 https://doi.org/10.1016/S0006-291X(02)00864-1
  72. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A. and Yamamoto, E. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-65 https://doi.org/10.1038/370061a0
  73. Schwarz, L.C., Gingras, M.C., Goldberg, G., Greenberg, A.H. and Wright, J.A. (1988). Loss of growth factor dependence and conversion of transforming growth factor-$\beta$1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res., 48, 6999-7003
  74. Sehgal, I. and Thompson, T.C. (1999). Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-$\beta$1 in human prostate cancer cell lines. Mol. Biol. Cell., 10, 407-416 https://doi.org/10.1091/mbc.10.2.407
  75. Shi, Y. and Massague, J. (2003). Mechanisms of TGF-$\beta$ signaling from cell membrane to the nucleus. Cell, 113, 685- 700 https://doi.org/10.1016/S0092-8674(03)00432-X
  76. Siegel, P.M., Shu, W., Cardiff, R.D., Muller, W.J. and Massague, J. (2003). Transforming growth factor $\beta$ signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. U.S.A., 100, 8430-8435
  77. Song, H., Ki, S.H., Kim, S.G. and Moon, A. (2006). Activating transcription factor (ATF)2 mediates MMP-2 transcriptional activation induced by p38 MAPK in breast epithelial cells. Cancer Res., 66, 10487-10496 https://doi.org/10.1158/0008-5472.CAN-06-1461
  78. Sternlicht, M.D., Lochter, A., Sympson, C.J., Huey, B., Rougier, J.P. and Gray, J.W. (1999). The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-146 https://doi.org/10.1016/S0092-8674(00)81009-0
  79. Stetler-Stevenson, W.G. (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9, 289- 303 https://doi.org/10.1007/BF00049520
  80. Taipale, J., Saharinen, J. and Keski-Oja, J. (1998). Extracellular matrix-associated transforming growth factor-$\beta$: role in cancer cell growth and invasion. Adv. Cancer Res., 75, 87-134 https://doi.org/10.1016/S0065-230X(08)60740-X
  81. Tanaka, Y., Nakayamada, S., Fujimoto, H., Okada, Y., Umehara, H. and Kataoka, T. (2002). H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts. J. Biol. Chem., 277, 21446-21452 https://doi.org/10.1074/jbc.M202238200
  82. Ten Dijke, P. and Hill, C.S. (2004). New insights into TGF-$\beta$- Smad signalling. Trends Biochem. Sci., 29, 265-273 https://doi.org/10.1016/j.tibs.2004.03.008
  83. Thiery, J.P. and Chopin, D. (1999). Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev., 18, 31-42 https://doi.org/10.1023/A:1006256219004
  84. Thiery, J.P. (2002). Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol., 15, 740-746 https://doi.org/10.1016/j.ceb.2003.10.006
  85. Tian, F., DaCosta Byfield, S., Parks, W.T., Yoo, S., Felici, A., Tang, B., Piek, E., Wakefield, L.M. and Roberts, A.B. (2003). Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res., 63, 8284-8292
  86. Tian, F., Byfield, S.D., Parks, W.T., Stuelten, C.H., Nemani, D., Zhang, Y.E. and Roberts, A.B. (2004). Smad-binding defective mutant of transforming growth factor $\beta$ type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res., 64, 4523- 4530 https://doi.org/10.1158/0008-5472.CAN-04-0030
  87. Tobin, S.W., Douville, K., Benbow, U., Brinckerhoff, C.E., Memoli, V.A. and Arrick, B.A. (2002). Consequences of altered TGF-$\beta$ expression and responsiveness in breast cancer: Evidence for autocrine and paracrine effects. Oncogene, 21, 108-118 https://doi.org/10.1038/sj.onc.1205026
  88. Tryggvason, K., Hoyhtya, M. and Pyke, C. (1993). Type IV collagenases in invasive tumors. Breast Cancer Res. Treat.,24, 209-218 https://doi.org/10.1007/BF01833261
  89. Tucker, R.F., Shipley, G.D., Moses, H.L. and Holley, R.W. (1984). Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science, 226, 705-707 https://doi.org/10.1126/science.6093254
  90. Ura, H., Bonfil, R.D., Reich, R., Reddel, R., Pfeifer, A., Harris, C.C. and Klein-Szanto, A.J. (1989). Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49, 4615-4621
  91. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.H. and Moustakas, A. (2005). TGF-$\beta$ and the Smad signaling pathway support transcriptomic reprogramming during epithelialmesenchymal cell transition. Mol. Biol. Cell., 16, 1987- 2002 https://doi.org/10.1091/mbc.E04-08-0658
  92. Wahl, S.M., Allen, J.B., Weeks, B.S., Wong, H.L. and Klotman, P.E. (1993). Transforming growth factor $\beta$ enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. U.S.A., 90, 4577-4581
  93. Watson, D.M., Elton, R.A., Jack, W.J., Dixon, J.M., Chetty, U. and Miller, W.R. (1991). The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res. Treat., 17, 161-169 https://doi.org/10.1007/BF01806365
  94. Welch, D.R., Fabra, A. and Nakajima, M. (1990). Transforming growth factor $\beta$ stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. U.S.A., 87, 7678-7682
  95. Whitman, M. (1998). Smads and early developmental signaling by the TGF$\beta$ superfamily. Genes Dev., 12, 2445-2462 https://doi.org/10.1101/gad.12.16.2445
  96. Wick, W., Platten, M. and Weller, M. (2001). Glioma cell invasion: regulation of metalloproteinase activity by TGF-$\beta$. J. Neurooncol., 53, 177-185 https://doi.org/10.1023/A:1012209518843
  97. Yan, Z., Winawer, S. and Friedman, E. (1994). Two different signal transduction pathways can be activated by transforming growth factor $\beta$1 in epithelial cells. J. Biol. Chem., 269, 13231-13237
  98. Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K. and Takahashi, T. (1998). Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-$\beta$ in human normal lung epithelial cells. Oncogene, 17, 1743-1747 https://doi.org/10.1038/sj.onc.1202052
  99. Yin, J.J., Selander, K., Chirgwin, J.M., Dallas, M., Grubbs, B.G., Wieser, R., Massague, J., Mundy, G.R. and Guise, T.A. (1999). TGF-$\beta$ signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest., 103, 197-206 https://doi.org/10.1172/JCI3523
  100. Yu, L., Hebert, M.C. and Zhang, Y.E. (2002). TGF-$\beta$ receptoractivated p38 MAP kinase mediates Smad-independent TGF-$\beta$ responses. EMBO J., 21, 3749-3759 https://doi.org/10.1093/emboj/cdf366
  101. Zhang, Y. and Derynck, R. (1999). Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell. Biol., 9, 274-279 https://doi.org/10.1016/S0962-8924(99)01579-2

Cited by

  1. CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation vol.11, pp.3, 2016, https://doi.org/10.1371/journal.pone.0151598